Serum IL-36 levels in AQP4-IgG-negative NMO patients were substantially higher than those in HCs (p = 0.001), but significantly lower than those in AQP4-IgG-positive NMO patients (p = 0.040). The gene discussed is AQP4; the disease is neuromyelitis optica.